McMaster University and Fusion Pharmaceuticals are working together to build a radiopharmaceutical manufacturing facility at MIP.
The new radiopharmaceutical manufacturing plant will be 27,000 square feet and Good Manufacturing Practice (GMP) certified. It’s a custom built space that will complement ongoing activities for Fusion Pharmaceuticals and leverage other resources to help companies commercialize innovative life sciences companies.
To read more about this exciting investment click here: https://globalnews.ca/news/7915662/new-radiopharmaceutical-manufacturing-facility-mcmaster-innovation-park/
